These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 12447834

  • 1. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
    Gierse JK, Staten NR, Casperson GF, Koboldt CM, Trigg JS, Reitz BA, Pierce JL, Seibert K.
    Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
    [Abstract] [Full Text] [Related]

  • 2. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH, Bai JY, Shen F, Bai AP, Guo ZR, Cheng GF.
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [Abstract] [Full Text] [Related]

  • 3. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS, Kozak KR, Crews BC, Hochgesang GP, Marnett LJ.
    J Med Chem; 1998 Nov 19; 41(24):4800-18. PubMed ID: 9822550
    [Abstract] [Full Text] [Related]

  • 4. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA.
    J Orthop Res; 2003 Jul 19; 21(4):670-5. PubMed ID: 12798067
    [Abstract] [Full Text] [Related]

  • 5. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C.
    J Soc Biol; 2000 Jul 19; 194(3-4):189-93. PubMed ID: 11324321
    [Abstract] [Full Text] [Related]

  • 6. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J, Kowalski ML.
    Pol Merkur Lekarski; 2001 Nov 19; 11(65):438-43. PubMed ID: 11852819
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
    Momin RA, De Witt DL, Nair MG.
    Phytother Res; 2003 Sep 19; 17(8):976-9. PubMed ID: 13680840
    [Abstract] [Full Text] [Related]

  • 8. Expression and enzyme activity determination of human cyclooxygenase-1 and -2 in a baculovirus-insect cell system.
    Zhang WY, Yang XN, Jin DZ, Zhu XZ.
    Acta Pharmacol Sin; 2004 Aug 19; 25(8):1000-6. PubMed ID: 15301731
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
    Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T.
    Int J Immunopathol Pharmacol; 2003 Aug 19; 16(2 Suppl):59-67. PubMed ID: 14552705
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effects of benzoisoselenothiazolidone sulfonamide derivatives on cyclooxygenase].
    Guo Y, Xiao YX, Guo ZR, Cheng GF.
    Yao Xue Xue Bao; 2001 Oct 19; 36(10):735-8. PubMed ID: 12579970
    [Abstract] [Full Text] [Related]

  • 11. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
    Hersh EV, Lally ET, Moore PA.
    Curr Med Res Opin; 2005 Aug 19; 21(8):1217-26. PubMed ID: 16083531
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD, Mitchell JA.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L.
    Am J Clin Oncol; 2003 Aug 15; 26(4):S66-9. PubMed ID: 12902859
    [Abstract] [Full Text] [Related]

  • 14. Defining COX-2 inhibitors.
    Lipsky PE.
    J Rheumatol Suppl; 2000 Oct 15; 60():13-6. PubMed ID: 11032097
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 17. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T, Shearer T, Azuma M.
    Curr Eye Res; 2004 Jul 01; 29(1):27-34. PubMed ID: 15370364
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G, Schulze-Osthoff K, Jänicke RU.
    Oncogene; 2003 Sep 11; 22(39):8021-30. PubMed ID: 12970750
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood.
    de Leval X, Delarge J, Devel P, Neven P, Michaux C, Masereel B, Pirotte B, David JL, Henrotin Y, Dogne JM.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Sep 15; 64(4-5):211-6. PubMed ID: 11418014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.